Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives

S. C. Joosten, L. Hamming, P. M. Soetekouw, M. J. Aarts, J. Veeck, M. van Engeland, V. C. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

62 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1-16
JournalBiochimica et Biophysica Acta-reviews on Cancer
Issue number1
Publication statusPublished - Jan 2015


  • Renal cell carcinoma
  • Kidney cancer
  • Targeted therapy
  • Sunitinib
  • Drug resistance
  • Biological tumor markers

Cite this